These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2674967)

  • 1. The interaction of alpha-1-acid glycoprotein with endogenous autocoids, in particular, platelet activating factor (PAF).
    McNamara PJ; Jewell RC; Gillespie MN
    Prog Clin Biol Res; 1989; 300():307-19. PubMed ID: 2674967
    [No Abstract]   [Full Text] [Related]  

  • 2. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
    McNamara PJ; Brouwer KR; Gillespie MN
    Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis.
    Macpherson JL; Kemp A; Rogers M; Mallet AI; Toia RF; Spur B; Earl JW; Chesterman CN; Krilis SA
    Clin Exp Immunol; 1989 Sep; 77(3):391-6. PubMed ID: 2805409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M; Zhang LZ; Lu JS
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paf-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-platelet activating factor antibody and its effects on platelet aggregation.
    Tatsumi N; Terano Y; Hashimoto K; Hiyoshi M; Matsuura S
    Osaka City Med J; 1993 Nov; 39(2):167-74. PubMed ID: 8183536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
    Saeed SA; Rasheed H
    Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
    Antonopoulou S; Tsoupras A; Baltas G; Kotsifaki H; Mantzavinos Z; Demopoulos CA
    Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
    Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependence of whole blood aggregation in response to platelet activating factor (PAF).
    Taylor RR; Strophair J; Sturm M; Vandongen R; Beilin LJ
    Thromb Haemost; 1988 Apr; 59(2):162-3. PubMed ID: 3388292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the production of platelet-activating factor by murine embryos and its putative role in the maternal physiology.
    Suzuki H; Taguchi Y; Kojima T; Nishihira J; Kanagawa H
    Biochem Mol Biol Int; 1995 Nov; 37(4):617-26. PubMed ID: 8589634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-dependent internalization of platelet-activating factor.
    Gerard NP; Gerard C
    J Immunol; 1994 Jan; 152(2):793-800. PubMed ID: 8283052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor-binding protein in human serum.
    Matsumoto M; Miwa M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():705-6. PubMed ID: 3004155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y
    Rinsho Byori; 1994 Jan; 42(1):63-9. PubMed ID: 8107285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.